Aphios Pharma LLC


Aphios® Pharma LLC is dedicated to the development and commercialization of FDA-approved, cannabis-based drugs for opioid addiction and other CNS disorders. We will manufacture and utilize pharmaceutical-grade natural cannabinoids in stable, bioavailable nanoformulations, in a DEA Schedule 1 facility to establish clinical evidence for treating highly unmet CNS disorders that are only partially and anecdotally addressed by medical marijuana.

Video Pitch

Management Team

President & CEO

Trevor Castor

Dr. Trevor P. Castor is President and Chief Executive Officer. He has over 30 years of diversified business experience from management, marketing and finance to technology and business development in the energy and biopharmaceutical industries. Dr. Castor graduated from the University of California, Berkeley with a Ph.D. in Mech. Eng. and a MS in Chem. Eng., and summa cum laude with a BS in Chem. Eng. from University of Toronto, Canada.

Chief Financial Officer and Controller

James Falese

Mr. James J. Falese, Chief Financial Officer and Controller, has 30 years of experience in all areas of accounting, cost and financial analysis, strategic planning, budgeting, inventory, financial controls and reporting with a strong expertise in manufacturing cost accounting, implementation of accounting systems, and information technology and human resources management. He holds a BS in Accounting from Merrimack College, North Andover, MA.

Director, Clincal and Regulatory Affairs

Judith Castor

Dr. Judith Palmer-Castor, Director of Clinical and Regulatory Affairs, is a behavioral health scientist with over 20 years of research, clinical and regulatory experiences in industry and academia. Dr. Palmer-Castor graduated with a Ph.D. in Policy with an emphasis on Behavioral Health and Adolescent Development from Brandeis University, Waltham, MA, and M.S. and B.S. degrees in Psychology from Santa Clara University, CA.